Product Information

AMLODIPINE-BENAZEPRIL 5-40 MG is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1492 per EA under NDC 57237014501. Its NADAC has been published 563 times since Feb 10, 2016.

FDA first approved this application on Sep 5, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-BENAZEPRIL 5-40 MG

Amlodipine and Benazepril Hydrochloride
$0.1492per EA

Strength

5; 40 mg/1; mg/1

NDC

57237014501

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202239

FDA Approved

9/5/2012

TE Code

AB

On Market Since

9/5/2012

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Decreased Blood Pressure
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-BENAZEPRIL 5-40 MG has been published 563 times since Feb 10, 2016, and over the history we have for it it has declined 62.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1492 per EA
All-time high$0.4144 (Mar 16, 2016)
All-time low$0.1069 (Jul 17, 2024)
52-week high$0.1492
52-week low$0.1373
Median price$0.1548
Average price$0.1779
Largest weekly change+55.2% (Aug 21, 2024)
Weeks tracked563
Tracking sinceFeb 10, 2016

Price History

1W

+1.6%

1M

+1.6%

3M

+1.4%

6M

+8.7%

1Y

+3.6%

3Y

-1.3%

5Y

-4.8%

All

-62.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-BENAZEPRIL 5-40 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-BENAZEPRIL 5-40 MG, manufactured by Rising Pharma Holdings Inc., is $0.1492 per EA (NDC 57237014501), effective Nov 18, 2026.

How has the price of AMLODIPINE-BENAZEPRIL 5-40 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-BENAZEPRIL 5-40 MG has declined 62.8%. It has been tracked across 563 weekly CMS publications since Feb 10, 2016.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-BENAZEPRIL 5-40 MG?

Since Feb 10, 2016, the NADAC for AMLODIPINE-BENAZEPRIL 5-40 MG has ranged from a low of $0.1069 (Jul 17, 2024) to a high of $0.4144 (Mar 16, 2016), with a median of $0.1548 per EA.

Are there cheaper alternatives to AMLODIPINE-BENAZEPRIL 5-40 MG?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-BENAZEPRIL 5-40 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-BENAZEPRIL 5-40 MG?

AMLODIPINE-BENAZEPRIL 5-40 MG (NDC 57237014501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.